Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,554,399 papers from all fields of science
Search
Sign In
Create Free Account
Extracellular Matrix Degradation
Extracellular Matrix Degradation consists of conjugation, transport, oxidation, and/or proteolysis of the supporting meshwork-like network of fibers…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
31 relations
ADAM15 protein, human
BMS-275291
C-Type Mannose Receptor 2
CAPN1 gene
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Leukotriene Receptor Antagonism and the Prevention of Extracellular Matrix Degradation During Atherosclerosis and In-Stent Stenosis
H. Hlawaty
,
M. Jacob
,
+5 authors
M. Bäck
Arteriosclerosis, Thrombosis and Vascular Biology
2009
Corpus ID: 18569549
Objective—The lipid-derived inflammatory mediators leukotrienes (LTs) are produced during vascular injury. The aim of the present…
Expand
2007
2007
Chinese yellow wine inhibits production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells.
Hangyuan Guo
,
Ping Wang
,
Binquan You
,
Y. Xing
,
Jong-dae Lee
Clinical Nutrition
2007
Corpus ID: 25228468
2004
2004
Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin)
J. Yoneda
,
I. Saiki
,
H. Fujii
,
F. Abe
,
Y. Kojima
,
I. Azuma
Clinical and Experimental Metastasis
2004
Corpus ID: 3763967
We have investigated the effect of the immunomodulator ubenimex (hereafter referred to as bestatin) on the enzymatic degradation…
Expand
2002
2002
Modeling extracellular matrix degradation balance with proteinase/transglutaminase cycle.
V. Larreta-Garde
,
H. Berry
Journal of Theoretical Biology
2002
Corpus ID: 23698945
Extracellular matrix mass balance is implied in many physiological and pathological events, such as metastasis dissemination…
Expand
1999
1999
Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease.
Y. Murawaki
,
Y. Ikuta
,
K. Okamoto
,
M. Koda
,
H. Kawasaki
Journal of Hepatology
1999
Corpus ID: 39059484
1997
1997
Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated…
J. Sipley
,
D. Alexander
,
J. Testa
,
J. Quigley
Proceedings of the National Academy of Sciences…
1997
Corpus ID: 25482903
Comparison of the amino acid sequence of the chicken and human urokinase-type plasminogen activators (uPAs) revealed that the…
Expand
1996
1996
Control of extracellular matrix degradation by interferon-gamma. The tryptophan connection.
J. Varga
,
T. Yufit
,
E. Hitraya
,
Raymond R. Brown
Advances in Experimental Medicine and Biology
1996
Corpus ID: 23522245
Interleukin-1 beta (IL-1 beta) is a potent signal for the induction of the matrix-degrading enzymes collagenase and stromelysin…
Expand
1995
1995
Regulation of plasminogen activation, matrix metalloproteinases and urokinase‐type plasminogen activator‐mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin…
A. de Bart
,
P. Quax
,
C. Löwik
,
J. Verheijen
Journal of Bone and Mineral Research
1995
Corpus ID: 35438809
Plasmin‐mediated extracellular proteolysis has been implicated in the degradation of bone in normal and pathological conditions…
Expand
Review
1994
Review
1994
Extracellular matrix degradation in parasitic diseases.
Z. Andrade
Brazilian journal of medical and biological…
1994
Corpus ID: 39702791
1. Fibrosis is an important manifestation of several parasitic diseases, but is not irreversible. A marked degree of…
Expand
1988
1988
Ultrastructural characteristics of new vessels in proliferative diabetic retinopathy.
J. M. Williams
,
E. de Juan
,
R. Machemer
American journal of ophthalmology-glaucoma
1988
Corpus ID: 39533452
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE